The sweets standing at the borderline between allo- and xenotransplantation

Xenotransplantation

Volumn 20, Issue 4, 2013, Pages 199-208

  Jang, Kyoung Soon ^a,c   Kim, Yun Gon ^b   Adhya, Mausumi ^a   Park, Hae Min ^a   Kim, Byung Gee ^a  

^a Seoul National University   (South Korea)

^b Soongsil University   (South Korea)

^c California Institute of Technology   (United States)

Author keywords

glycan database; mass spectrometry; non Gal antigen; pig glycome; xenotransplantation

Indexed keywords

CARBOHYDRATE ANTIGEN; GALACTOSYLTRANSFERASE; GLYCAN; GLYCOSPHINGOLIPID;

CARBOHYDRATE ANALYSIS; GLYCOBIOLOGY; GLYCOSYLATION; GRAFT FAILURE; GRAFT REJECTION; HISTOCOMPATIBILITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SWINE; XENOTRANSPLANTATION;

GLYCAN DATABASE; MASS SPECTROMETRY; NON-GAL ANTIGEN; PIG GLYCOME; XENOTRANSPLANTATION;

ALLOGRAFTS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS; GALACTOSYLTRANSFERASES; GENE KNOCKOUT TECHNIQUES; GRAFT REJECTION; HETEROGRAFTS; HUMANS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84881169732     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/xen.12030     Document Type: Review

References (81)

1. Farr AD,. The first human blood transfusion. Med Hist 1980; 24: 143-162.
2. Morgan WT, Watkins WM,. Some aspects of the biochemistry of the human blood-group substances. Br Med Bull 1959; 15: 109-113.
3. Taniguchi S, Cooper DK,. Clinical xenotransplantation: past, present and future. Ann R Coll Surg Engl 1997; 79: 13-19.
4. Adams DH, Chen RH, Kadner A,. Cardiac xenotransplantation: clinical experience and future direction. Ann Thorac Surg 2000; 70: 320-326.
5. Sim KH, Marinov A, Levy GA,. Xenotransplantation: a potential solution to the critical organ donor shortage. Can J Gastroenterol 1999; 13: 311-318.
6. Hammer C,. Xenotransplantation and its future. Forensic Sci Int 1994; 69: 259-268.
7. Bailey LL,. Another look at cardiac xenotransplantation. J Card Surg 1990; 5: 210-218.
8. Chen G, Qian H, Starzl T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005; 11: 1295-1298.
9. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29-31.
10. Kolber-Simonds D, Lai L, Watt SR, et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A 2004; 101: 7335-7340.
11. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411-414.
12. Oriol R, Ye Y, Koren E, Cooper DK,. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433-1442.
13. Good AH, Cooper DK, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559-562.
14. Cooper DK, Koren E, Oriol R,. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994; 141: 31-58.
15. Varki A,. Essentials of Glycobiology, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2009, xxix, 784.
16. Paulson JC, Blixt O, Collins BE,. Sweet spots in functional glycomics. Nat Chem Biol 2006; 2: 238-248.
17. Rudd PM, Elliott T, Cresswell P, et al. Glycosylation and the immune system. Science 2001; 291: 2370-2376.
18. Ezzelarab M, Ayares D, Cooper DK,. Carbohydrates in xenotransplantation. Immunol Cell Biol 2005; 83: 396-404.
19. Milland J, Sandrin MS,. ABO blood group and related antigens, natural antibodies and transplantation. Tissue Antigens 2006; 68: 459-466.
20. Rydberg L, Molne J, Strokan V, et al. Histo-blood group A antigen expression in pig kidneys-implication for ABO incompatible pig-to-human xenotransplantation. Scand J Urol Nephrol 2001; 35: 54-62.
21. Ye Y, Niekrasz M, Kehoe M, et al. Cardiac allotransplantation across the ABO-blood group barrier by the neutralization of preformed antibodies: the baboon as a model for the human. Lab Anim Sci 1994; 44: 121-124.
22. Freeze HH,. Genetic defects in the human glycome. Nat Rev Genet 2006; 7: 537-551.
23. Fuster MM, Esko JD,. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 2005; 5: 526-542.
24. Marklova E, Albahri Z,. Screening and diagnosis of congenital disorders of glycosylation. Clin Chim Acta 2007; 385: 6-20.
25. Brooks SA, Carter TM, Royle L, et al. Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. Anticancer Agents Med Chem 2008; 8: 2-21.
26. Dall'Olio F, Trere D,. Expression of alpha 2,6-sialylated sugar chains in normal and neoplastic colon tissues. Detection by digoxigenin-conjugated Sambucus nigra agglutinin. Eur J Histochem 1993: 37: 257-265.
27. Passaniti A, Hart GW,. Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures. J Biol Chem 1988; 263: 7591-7603.
28. Cummings RD,. The repertoire of glycan determinants in the human glycome. Mol BioSyst 2009; 5: 1087-1104.
29. Chen X, Andreana PR, Wang PG,. Carbohydrates in transplantation. Curr Opin Chem Biol 1999; 3: 650-658.
30. Malhotra R, Wormald MR, Rudd PM, et al. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995; 1: 237-243.
31. Smith PL, Bousfield GR, Kumar S, et al. Equine lutropin and chorionic gonadotropin bear oligosaccharides terminating with SO4-4-GalNAc and Sia alpha 2,3Gal, respectively. J Biol Chem 1993; 268: 795-802.
32. Callewaert N, Schollen E, Vanhecke A, et al. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I. Glycobiology 2003; 13: 367-375.
33. Dennis JW, Granovsky M, Warren CE,. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1999; 1473: 21-34.
34. Orntoft TF, Vestergaard EM,. Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis 1999; 20: 362-371.
35. Patani N, Jiang W, Mokbel K,. Prognostic utility of glycosyltransferase expression in breast cancer. Cancer Genomics Proteomics 2008; 5: 333-340.
36. Iwai T, Kudo T, Kawamoto R, et al. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc Natl Acad Sci U S A 2005; 102: 4572-4577.
37. Kawano S, Hashimoto K, Miyama T, et al. Prediction of glycan structures from gene expression data based on glycosyltransferase reactions. Bioinformatics 2005; 21: 3976-3982.
38. Satomaa T, Heiskanen A, Leonardsson I, et al. Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. Cancer Res 2009; 69: 5811-5819.
39. Stumpo KA, Reinhold VN,. The N-glycome of human plasma. J Proteome Res 2010; 9: 4823-4830.
40. Pang PC, Tissot B, Drobnis EZ, et al. Analysis of the human seminal plasma glycome reveals the presence of immunomodulatory carbohydrate functional groups. J Proteome Res 2009; 8: 4906-4915.
41. Satomaa T, Heiskanen A, Mikkola M, et al. The N-glycome of human embryonic stem cells. BMC Cell Biol 2009; 10: 42.
42. Cooper CA, Harrison MJ, Wilkins MR, Packer NH,. GlycoSuiteDB: a new curated relational database of glycoprotein glycan structures and their biological sources. Nucleic Acids Res 2001; 29: 332-335.
43. Kanehisa M, Goto S, Kawashima S, et al. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004: 32 (Database issue): D277-D280.
44. Nakahara T, Hashimoto R, Nakagawa H, et al., Glycoconjugate Data Bank: Structures-an annotated glycan structure database and N-glycan primary structure verification service. Nucleic Acids Res 2008: 36 (Database issue): D368-D371.
45. Hammer C, Chaussy C, Brendel W,. Preformed natural antibodies in animals and man. Outlook on xenotransplantation. Eur Surg Res 1973; 5: 162-166.
46. Galili U,. Evolution of alpha 1,3galactosyltransferase and of the alpha-Gal epitope. Subcell Biochem 1999; 32: 1-23.
47. Galili U,. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480-482.
48. Galili U, Macher BA, Buehler J, Shohet SB,. Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1-3)-linked galactose residues. J Exp Med 1985; 162: 573-582.
49. Oriol R, Barthod F, Bergemer AM, et al. Monomorphic and polymorphic carbohydrate antigens on pig tissues: implications for organ xenotransplantation in the pig-to-human model. Transpl Int 1994; 7: 405-413.
50. Taniguchi S, Neethling FA, Korchagina EY, et al. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column. Transplantation 1996; 62: 1379-1384.
51. Ramsoondar JJ, Machaty Z, Costa C, et al. Production of alpha 1,3-galactosyltransferase-knockout cloned pigs expressing human alpha 1,2-fucosylosyltransferase. Biol Reprod 2003; 69: 437-445.
52. Auchincloss H Jr, Sachs DH,. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433-470.
53. Yeh P, Ezzelarab M, Bovin N, et al. Investigation of potential carbohydrate antigen targets for human and baboon antibodies. Xenotransplantation 2010; 17: 197-206.
54. Byrne GW, Stalboerger PG, Davila E, et al. Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation. Xenotransplantation 2008; 15: 268-276.
55. Chen G, Sun H, Yang H, et al. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation 2006; 81: 273-283.
56. Lam TT, Paniagua R, Shivaram G, et al. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys. Xenotransplantation 2004; 11: 531-535.
57. Nakarai H, Chandler PJ, Kano K, et al. Hanganutziu-Deicher antigen as a possible target for immunotherapy of melanoma. Int Arch Allergy Appl Immunol 1990; 91: 323-328.
58. Kawachi S, Saida T,. Analysis of the expression of Hanganutziu-Deicher (HD) antigen in human malignant melanoma. J Dermatol 1992; 19: 827-830.
59. Mukuria CJ, Noguchi A, Suzuki E, Naiki M,. Potential use of specific human and chicken antibodies for detection of Hanganutziu-Deicher antigen(s) in sera of cancer patients. Jpn J Med Sci Biol 1994; 47: 253-264.
60. Higashi H, Hirabayashi Y, Fukui Y, et al. Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer. Cancer Res 1985; 45: 3796-3802.
61. Basnet NB, Ide K, Tahara H, et al. Deficiency of N-glycolylneuraminic acid and Galalpha1-3Galbeta1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies. Xenotransplantation 2010; 17: 440-448.
62. Byrne GW, Stalboerger PG, Du Z, et al. Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation. Transplantation 2011; 91: 287-292.
63. Dor FJ, Cheng J, Alt A, et al. Gal alpha 1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus. Xenotransplantation 2004; 11: 101-106.
64. Heald KA, Carless N, Jay TR, et al. Expression of the GALalpha(1-3)GAL epitope on pig islets. J Mol Med 1999; 77: 169-171.
65. Kirkeby S, Moe D,. Lectin interactions with alpha-galactosylated xenoantigens. Xenotransplantation 2002; 9: 260-267.
66. Lee HI, Kim MK, Oh JY, et al. Gal alpha(1-3)Gal expression of the cornea in vitro, in vivo and in xenotransplantation. Xenotransplantation 2007; 14: 612-618.
67. McKenzie IF, Xing PX, Vaughan HA, et al. Distribution of the major xenoantigen (gal (alpha 1-3)gal) for pig to human xenografts. Transpl Immunol 1994; 2: 81-86.
68. Kim YG, Gil GC, Harvey DJ, Kim BG,. Structural analysis of alpha-Gal and new non-Gal carbohydrate epitopes from specific pathogen-free miniature pig kidney. Proteomics 2008; 8: 2596-2610.
69. Kim YG, Gil GC, Jang KS, et al. Qualitative and quantitative comparison of N-glycans between pig endothelial and islet cells by high-performance liquid chromatography and mass spectrometry-based strategy. J Mass Spectrom 2009; 44: 1087-1104.
70. Kim YG, Oh JY, Gil GC, et al. Identification of alpha-Gal and non-Gal epitopes in pig corneal endothelial cells and keratocytes by using mass spectrometry. Curr Eye Res 2009; 34: 877-895.
71. Mechref Y, Novotny MV,. Glycomic analysis by capillary electrophoresis-mass spectrometry. Mass Spectrom Rev 2009; 28: 207-222.
72. Morelle W, Michalski JC,. Analysis of protein glycosylation by mass spectrometry. Nat Protoc 2007; 2: 1585-1602.
73. Zaia J,. Mass spectrometry and the emerging field of glycomics. Chem Biol 2008; 15: 881-892.
74. Zaia J,. Mass spectrometry and glycomics. OMICS 2010; 14: 401-418.
75. Kim YG, Harvey DJ, Yang YH, et al. Mass spectrometric analysis of the glycosphingolipid-derived glycans from miniature pig endothelial cells and islets: identification of NeuGc epitope in pig islets. J Mass Spectrom 2009; 44: 1489-1499.
76. Kim YG, Kim SY, Hur YM, et al. The identification and characterization of xenoantigenic nonhuman carbohydrate sequences in membrane proteins from porcine kidney. Proteomics 2006; 6: 1133-1142.
77. Keusch JJ, Manzella SM, Nyame KA, et al. Expression cloning of a new member of the ABO blood group glycosyltransferases, iGb3 synthase, that directs the synthesis of isoglobo-glycosphingolipids. J Biol Chem 2000; 275: 25308-25314.
78. Milland J, Christiansen D, Lazarus BD, et al. The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene. J Immunol 2006; 176: 2448-2454.
79. Diswall M, Angstrom J, Karlsson H, et al. Structural characterization of alpha1,3-galactosyltransferase knockout pig heart and kidney glycolipids and their reactivity with human and baboon antibodies. Xenotransplantation 2010; 17: 48-60.
80. Morozumi K, Kobayashi T, Usami T, et al. Significance of histochemical expression of Hanganutziu-Deicher antigens in pig, baboon and human tissues. Transplant Proc 1999; 31: 942-944.
81. Bouhours D, Liaigre J, Naulet J, et al. A novel glycosphingolipid expressed in pig kidney: Gal alpha 1-3Lewis(x) hexaglycosylceramide. Glycoconj J 1997; 14: 29-38.